Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease. European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone"
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Deferiprone (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms FAIR-PARK-II
- 21 Apr 2016 Status changed from not yet recruiting to recruiting.
- 27 Jan 2016 New trial record